- In August 2021, Yuyu Pharma secured exclusive distribution rights for three prescription drugs, including Tegretol, through an agreement with Novartis Korea. This deal enables Yuyu Pharma to expand its epilepsy treatment portfolio, improving patient access to carbamazepine-based therapies. The collaboration strengthens Yuyu’s position in the neurological drug market and supports broader availability of essential epilepsy medications
- In February 2021, Koninklijke Philips N.V. acquired BioTelemetry, Inc., a leading company in remote diagnostics and patient monitoring. This acquisition enhances Philips’ capabilities in digital health and remote care solutions, allowing better management of chronic conditions such as epilepsy. The move is expected to drive innovation in continuous monitoring technologies, improving patient outcomes and shaping the future of telehealth in neurological care
